Presentation is loading. Please wait.

Presentation is loading. Please wait.

Antithrombotic therapy after infrainguinal bypass

Similar presentations


Presentation on theme: "Antithrombotic therapy after infrainguinal bypass"— Presentation transcript:

1 Antithrombotic therapy after infrainguinal bypass
Mario Maufus, MD, Gilles Pernod, MD, PhD  Journal of Vascular Surgery  Volume 60, Issue 5, Pages (November 2014) DOI: /j.jvs Copyright © 2014 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Efficacy and tolerance of antithrombotic drugs reported for all infrainguinal bypasses. The open boxes indicate occlusion/amputation, and the black boxes indicate hemorrhages. Patency was reported at 3 years,a 1 year,b 5 years,c and 2 years,d as originally reported. The relative risk (RR) or hazard ratio (HR) are shown as originally reported when available or the RR was calculated from the original data.*Occlusion was reported based on the analysis of primary and primary assisted patency. ¤Includes death, and gastrointestinal (GI), central nervous system (CNS), and genitourinary (GU) complications. ASA, Acetylsalicylic acid; CASA, combination of clopidogrel and acetylsalicylic acid; W, warfarin; WASA, combination of warfarin and aspirin. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Efficacy and tolerance of antithrombotic drugs reported for venous infrainguinal bypasses. The open boxes are for occlusion/amputation, and the black boxes are for hemorrhages. Patency was reported at 3 years,a 1 year,b 5 years,c and 2 years,d as originally reported. The relative risk (RR) or hazard ratio (HR) are shown as originally reported when available, or the RR was calculated from the original data.*Occlusion was reported based on the analysis of primary and primary assisted patency. ¤Includes death and gastrointestinal (GI), central nervous system (CNS), and genitourinary (GU) complications. ASA, Acetylsalicylic acid; CASA, combination of clopidogrel and acetylsalicylic acid; W, warfarin; WASA, combination of warfarin and aspirin. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Efficacy and tolerance of antithrombotic drugs reported for prosthetic infrainguinal bypasses. The open boxes are for occlusion/amputation, and the black boxes are for hemorrhages. Patency was reported at 1 year,a 5 years,b and 2 years,c as originally reported. The relative risk (RR) or hazard ratio (HR) are shown as originally reported when available, or the RR was calculated from the original data. *Occlusion was reported based on the analysis of primary and primary assisted patency. ¤Includes death and gastrointestinal (GI), central nervous system (CNS) and genitourinary (GU) complications. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2014 Society for Vascular Surgery Terms and Conditions


Download ppt "Antithrombotic therapy after infrainguinal bypass"

Similar presentations


Ads by Google